The Cooper Companies, Inc.

NASDAQ:COO

Medical - Instruments & Supplies

Healthcare
$60.75 -3.42%

-$2.30 today

Market cap
$11.55B
Beta
0.87
P/E (TTM)
53.8
EPS (TTM)
$1.21
52W Low $58.89High $89.83

Volume 2.20M

Average 2.55M

COO Other Financing Activities

Financing cash flows not reported separately.

The Cooper Companies, Inc.NASDAQ: COO

Other Financing Activities · Q3 FY2026 · quarter ended Jul 2026

Other financing activities turns negative

Q3 FY2026 other financing activities was -$573.9M, compared with $0 a year earlier. Trailing-twelve-month other financing activities was -$646.8M. Over 3 fiscal years it compounded at +54.0% a year.

Context

  • Other financing activities amounted to 1.8% of revenue in FY2025, up 1.0 pp from a year earlier.
  • Other financing activities grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other financing activities holds near -$573.9M or moves back toward the trailing-twelve-month quarterly average of -$161.7M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
-$573.9M+2508.6% QoQ
Last fiscal yearOct 2025
-$71.9M+137.3% YoY
LTMJul 2026
-$646.8M+524.3% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+137.3%——
3-year CAGR+54.0%——
5-year CAGR——
10-year CAGR——

Other Financing Activities history

USD · from the cash flow

Latest · FY2025
(71.9M) USD
Year-over-year change
-137.3%

Other Financing Activities vs competitors

How COO compares with its peers on the latest reported figures

  • COO's LTM Jul 2026 other financing activities of $646.8M is the 2nd largest of the 6 companies compared; the peer median is $319K.
  • Its year-over-year change of +524.3% is the highest of 6, against a peer median of +11.6%.
  • Other financing activities amounts to 15.3% of revenue for COO, versus a peer median of 0.9%.
COO Competitors Peer median
Other Financing Activities for COO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$649.76M +380.0%+77.4%5.9%
COOThe Cooper Companies, Inc.LTM Jul 2026$646.8M +524.3%+54.0%15.3%
GKOSGlaukos CorporationLTM Jun 2026$12.9M -70.4%+49.6%2.1%
STAASTAAR Surgical CompanyLTM Apr 2026$2.73M +11.6%—0.9%
BLCOBausch + Lomb CorporationLTM Jun 2026$499.55K -98.7%-78.4%0.0%
LNSRLENSAR, Inc.LTM Mar 2026$319K +82.3%—0.6%
Peer median (excluding COO) $319K+11.6%+49.6%0.9%

Competitors are the stored peer set for COO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Net Income2.94B385.8M294.2M392.3M374.9M
Depreciation & Amortization309.3M346.1M367.7M375.1M423M
Deferred Income Tax(2.5B)53.9M44.7M118.9M135.2M
Stock-Based Compensation00000
Change in Working Capital(149.9M)(174M)(218.8M)(333.7M)(284.8M)
Accounts Receivables(75.5M)(33.8M)(60.2M)(117.1M)(120.3M)
Inventory(9.2M)(40.4M)(105.4M)(59.3M)(46M)
Accounts Payables(16M)49.9M5.5M9.3M8M
Other Working Capital(49.2M)(149.7M)(58.7M)(166.6M)(126.5M)
Other Non-Cash Items136.7M80.6M119.7M156.7M147.8M
Operating Cash Flow738.6M692.4M607.5M709.3M796.1M
Capital Expenditures(214.4M)(242M)(392.5M)(421.2M)(362.4M)
Acquisitions (Net)0(1.59B)(56.5M)(343.4M)(10.5M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(235.9M)0000
Investing Cash Flow(450.3M)(1.83B)(449M)(764.6M)(372.9M)
Debt Repayment(309.9M)1.28B(180.8M)5.6M(79.9M)
Common Stock Issued26.3M16.1M23M63.9M16M
Common Stock Repurchased(24.8M)(78.5M)00(290.1M)
Dividends Paid(3M)(3M)(3M)00
Other Financing Activities0(19.7M)(13.1M)(30.3M)(71.9M)
Financing Cash Flow(311.4M)1.19B(173.9M)39.2M(425.9M)
Effect of Forex Changes2.6M(12.6M)(2.3M)2.9M5.6M
Net Change in Cash(20.5M)42.3M(17.7M)(13.2M)2.9M
Free Cash Flow524.2M450.4M215M288.1M433.7M

The Cooper Companies, Inc.

NASDAQ:COO

Intrinsic Alpha fair value

Locked

Current Price

$60.75

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.